Behrad Derakhshan, Ph.D., is a distinguished professional who currently holds the position of Chief Business Officer at Edgewise Therapeutics Inc. With a robust background in biotechnology and pharmaceuticals, Dr. Derakhshan has made significant contributions to the industry through his strategic leadership and expertise in business development. He earned his Ph.D. in Biochemistry from the University of California, San Francisco, where his research focused on understanding the molecular mechanisms of disease, laying a solid foundation for his career in drug development. Throughout his career, Dr. Derakhshan has held key positions at several leading biotech firms, where he played pivotal roles in advancing therapeutic programs from early-stage research to clinical development. Prior to joining Edgewise Therapeutics, he served as the Vice President of Business Development at a prominent biopharmaceutical company, where he was instrumental in forging strategic partnerships and securing substantial funding for innovative projects. His achievements include the successful negotiation of multiple licensing agreements and collaborations that have accelerated the development of novel treatments for various diseases. As Chief Business Officer at Edgewise Therapeutics, Dr. Derakhshan is responsible for overseeing the company's business strategy and development initiatives. His role involves identifying and pursuing opportunities for partnerships, mergers, and acquisitions that align with Edgewise's mission to develop transformative treatments for muscle disorders. Under his leadership, the company has made significant strides in expanding its portfolio and advancing its pipeline of muscle-focused therapies. Dr. Derakhshan's strategic vision and dedication to scientific excellence continue to drive Edgewise Therapeutics towards its goal of improving the lives of patients worldwide.